1-20 of 26
Mohamed Sorror
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Socioeconomic Factors on Access to and Outcomes of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) for Acute Myeloid Leukemia (AML): A Multi-Center Observational Study

Natalie Wuliji, Ted Gooley, Salene Jones, Aaron T. Gerds, Bruno Medeiros, Paul J. Shami, John Galvin, Kehinde Adekola, Selina Luger, Maria R. Baer, David A. Rizzieri, Tanya M. Wildes, Eunice S. Wang, Mikkael A. Sekeres, Sudipto Mukherjee, Julie C. Smith, Mitchell A. Garrison, Kiarash Kojouri, Jacob S. Appelbaum, Mary-Elizabeth M. Percival, Brenda M. Sandmaier, Frederick R. Appelbaum, Mohamed Sorror
Journal: Blood
Blood (2024) 144 (Supplement 1): 6.
https://doi.org/10.1182/blood-2024-202664
Published: 2024
Journal Articles

The Composite Health Risk Assessment Model (CHARM) Predicts Risks of Toxicities, Functional and Cognitive Decline Among Survivors of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): A Prospective BMT-CTN Study 1704

Mohamed Sorror, Wael Saber, Brent R. Logan, Nancy Geller, Anna Bellach, Jianqun Kou, William A. Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Asmita Mishra, Joseph Uberti, Parastoo B Dahi, Jennifer N. Saultz, Shannon R McCurdy, Lawrence E Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Rebecca Olin, Joseph E. Maakaron, Ronald Sobecks, Sarah A. Wall, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Andrew Artz
Journal: Blood
Blood (2024) 144 (Supplement 1): 685.
https://doi.org/10.1182/blood-2024-194414
Published: 2024
Journal Articles

Prognostic Understanding for Older, Medically Infirm, and/or Frail Recipients of Allogeneic Hematopoietic Cell Transplantation in an Ongoing Seamless Phase 2/3 Randomized Interventional Trial (ACE-BMT)

Elizabeth T. Loggers, James Fausto, Matthew Givens, Mei-Ean Yeow, Reena V. Jayani, Hassan B Alkhateeb, Laura A Schoenherr, Michael W. Rabow, Mark B Juckett, George Carrum, Joseph Uberti, Kyle Neale, Santiago Lopez, Diana Martins-Welch, Jeanette G Ferrer, Laura S Rhee, Drew A Rosielle, Susan McInnes, Jason A Webb, Rachel J. Cook, Elisheva Newman, Ronald Sobecks, Laura Johnston, Mohamed Sorror
Journal: Blood
Blood (2024) 144 (Supplement 1): 2297.
https://doi.org/10.1182/blood-2024-212281
Published: 2024
Journal Articles

A Comparison of Different Comorbidity Indices in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): Comprehensibility Vs Simplicity Vs Objectivity

Lorenzo Iovino, Ningxin Ma, Chris Davis, Linda M Glockling, Sophie L Martin, Filippo Milano, Jordan Gauthier, Naveed Ali, Ted Gooley, Qian Vicky Wu, Mohamed Sorror
Journal: Blood
Blood (2024) 144 (Supplement 1): 4919.
https://doi.org/10.1182/blood-2024-193595
Published: 2024
Journal Articles

Class III Obesity Is Associated with Worse Overall Survival in Previously Untreated Younger Patients with Acute Myeloid Leukemia Enrolled on SWOG 1203

Michelle Y. Zhang, Megan Othus, Kerry K McMillen, Harry P. Erba, Guillermo Garcia-Manero, John Pagel, Mohamed Sorror, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2023) 142 (Supplement 1): 2863.
https://doi.org/10.1182/blood-2023-189455
Published: 2023
Journal Articles

Predictors of Cytokine Release Syndrome and Neurotoxicity in Patients with Large B-Cell Lymphoma and Their Impact on Survival

Roni Shouval, Christopher Strouse, Soyoung Kim, Temitope Oloyede, Sairah Ahmed, Farrukh T. Awan, Veronika Bachanova, Talha Badar, Pere Barba, Amer M. Beitinjaneh, Amanda F Cashen, Bhagirathbhai Dholaria, Mahmoud Elsawy, Siddhartha Ganguly, Praveen Ramakrishnan Geethakumari, Uri Greenbaum, Hamza Hashmi, Laquisa C. Hill, Michael D. Jain, Tania Jain, Partow Kebriaei, Adam S Kittai, Frederick L. Locke, Premal D. Lulla, Elena Mead, Joseph P McGuirk, Alberto Mussetti, Taiga Nishihori, Amanda L. Olson, Martina Pennisi, Miguel-Angel Perales, Peter A. Riedell, Wael Saber, Sayeef Mirza, Margarida Magalhaes-Silverman, Elizabeth J. Shpall, Mohamed Sorror, Kitsada Wudhikarn, Cameron J. Turtle, Marcelo Pasquini, Amy Moskop
Journal: Blood
Blood (2023) 142 (Supplement 1): 355.
https://doi.org/10.1182/blood-2023-181181
Published: 2023
Journal Articles

The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704

Andrew Artz, Brent R. Logan, Wael Saber, Nancy Geller, Anna Bellach, Jianqun Kou, William Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Tammy Schuler, Asmita Mishra, Joseph Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R McCurdy, Lawrence Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Mohamed Sorror
Journal: Blood
Blood (2023) 142 (Supplement 1): 109.
https://doi.org/10.1182/blood-2023-173855
Published: 2023
Journal Articles

Allogeneic Hematopoietic Cell Transplantation in the 7 th Decade of Life and Beyond

Mary-Elizabeth M. Percival, Ted Gooley, Chris Davis, Ryan S. Basom, Stephanie J. Lee, Frederick R. Appelbaum, Mohamed Sorror
Journal: Blood
Blood (2023) 142 (Supplement 1): 3608.
https://doi.org/10.1182/blood-2023-185037
Published: 2023
Journal Articles

Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)

Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Farrukh T. Awan, Umar Farooq, Siddhartha Ganguly, Peiman Hematti, Michael D. Jain, Partow Kebriaei, Frederick L. Locke, Elena Mead, Taiga Nishihori, Amanda L. Olson, Martina Pennisi, Miguel-Angel Perales, Praveen Ramakrishnan Geethakumari, Roni Shouval, Elizabeth J. Shpall, Margarida Magalhaes Magalhaes-Silverman, Christopher Strouse, Cameron J. Turtle, Anusha Vallurupalli, Kitsada Wudhikam, Marcelo C. Pasquini, Sairah Ahmed, Mohamed Sorror
Journal: Blood
Blood (2022) 140 (Supplement 1): 4636–4638.
https://doi.org/10.1182/blood-2022-169452
Published: 2022
Journal Articles

Expanded Comorbidity Definitions Improve Applicability of the Hematopoietic Stem Cell Transplantation-Comorbidity Index for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Stem Cell Transplantation

Brian D Friend, MD, Larisa Broglie, MD MS, Brent Logan, PhD, Caitrin Fretham, MPH, Gary J. Schiller, MD, Bipin N. Savani, MD, Edward Stadtmauer, Saurabh Chhabra, MD, Marcelo C. Pasquini, MDMS, Monica Thakar, MD, Mohamed Sorror, MD MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-140778
Published: 2020
Journal Articles

Expanded Comorbidity Definitions Improve Application of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for Children and Young Adults with Non-Malignant Diseases Receiving Allogeneic Hematopoietic Cell Transplantation

Larisa Broglie, MD MS, Brian D Friend, MD, Brent Logan, PhD, Caitrin Fretham, MPH, Gary J. Schiller, MD, Bipin N. Savani, MD, Edward A. Stadtmauer, MD FACP, Saurabh Chhabra, MD, Marcelo C. Pasquini, MDMS, Monica Thakar, MD, Mohamed Sorror, MD MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-140637
Published: 2020
Journal Articles

Non-Infectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation (HCT): A Center for International Blood and Marrow Transplant Research (CIBMTR) Study

Sagar S. Patel, MD, Kwang Woo Ahn, PhD, Manoj Khanal, BS, MS, Caitrin Fretham, MPH, Celalettin Ustun, MD, Betty K. Hamilton, MD, Navneet S. Majhail, MD MS, Shin Mineishi, MD, Bipin N. Savani, MD, Mohamed Sorror, MD MSc, Edward A. Stadtmauer, MD FACP, Brent Logan, PhD, Marcelo C. Pasquini, MDMS, Saurabh Chhabra, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-140503
Published: 2020
Journal Articles

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS

Clinical Trials & Observations
H. Joachim Deeg, Bart L. Scott, Min Fang, Howard M. Shulman, Boglarka Gyurkocza, David Myerson, John M. Pagel, Uwe Platzbecker, Aravind Ramakrishnan, Jerald P. Radich, Brenda M. Sandmaier, Mohamed Sorror, Derek L. Stirewalt, Wendy A. Wilson, Rainer Storb, Frederick R. Appelbaum, Ted Gooley
Journal: Blood
Blood (2012) 120 (7): 1398–1408.
https://doi.org/10.1182/blood-2012-04-423046
Published: 2012
Includes: Supplemental data
Journal Articles

Comorbidity, Lactate Dehydrogenase (LDH), and Chemosensitivity Are Independent Predictors of Mortality after Autologous Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Lymphoma.

Mohamed Sorror, B. Storer, A. Gopal, L. Holmberg, B.M. Sandmaier, W.I. Bensinger, D.G. Maloney, O.W. Press, R.F. Storb
Journal: Blood
Blood (2007) 110 (11): 616.
https://doi.org/10.1182/blood.V110.11.616.616
Published: 2007
Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) after Non-Myeloablative Conditioning in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL).

Andrew R. Rezvani, MD, L. Norasetthada, MD, T. Gooley, PhD, Mohamed Sorror, MD, Stephen J. Forman, MD, Edward Agura, MD, T. Chauncey, MD, PhD, Richard T. Maziarz, MD, Michael Maris, MD, J. Shizuru, MD, PhD, B. Bruno, MD, James C. Wade, MD, T. Lange, MD, Andrew Yeager, MD, Brenda M. Sandmaier, MD, Rainer F. Storb, MD, David G. Maloney, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3037.
https://doi.org/10.1182/blood.V110.11.3037.3037
Published: 2007
Journal Articles

Impacts of Comorbidities on Outcomes of Patients (pts) Diagnosed with B-Cell Malignancies and Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative (NM) vs Myeloablative (M) Conditioning.

Mohamed Sorror, MD, MSc, Brenda M. Sandmaier, MD, Barry Storer, PhD, Michael B. Maris, MD, David G. Maloney, MD, PhD, Rainer Storb, MD
Journal: Blood
Blood (2006) 108 (11): 550.
https://doi.org/10.1182/blood.V108.11.550.550
Published: 2006
Journal Articles

Serious Acute or Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplantation: A Comparison of Myeloablative and Non-Myeloablative Conditioning Regimens.

Olga Sala-Torra, MD, Paul J. Martin, MD, Barry Storer, PhD, Mohamed Sorror, MD, Rainer F. Storb, MD, Brenda M. Sandmaier, MD, Mary E.D. Flowers, MD
Journal: Blood
Blood (2006) 108 (11): 755.
https://doi.org/10.1182/blood.V108.11.755.755
Published: 2006
Journal Articles

The Joint Role of Comorbidity and Performance Status (PS) in Predicting Morbidity after Allogeneic Nonmyeloablative Hematopoietic Cell Transplantation (HCT).

Mohamed Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, David G. Maloney, MD, PhD, Michael Pulsipher, MD, Amelia Langston, MD, Michael B. Maris, MD, Dietger Niederwieser, MD, Rainer Storb, MD
Journal: Blood
Blood (2006) 108 (11): 596.
https://doi.org/10.1182/blood.V108.11.596.596
Published: 2006
Journal Articles

Relationship between Conditioning Intensity and Comorbidity in Patients (Pts) with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Receiving Allogeneic Hematopoietic Cell Transplantation (HCT).

Mohamed Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, Michael Maris, MD, Frederic Baron, MD, PhD, David Maloney, MD, PhD, Bart Scott, MD, H. Joachim Deeg, MD, Rainert Storb, MD
Journal: Blood
Blood (2005) 106 (11): 705.
https://doi.org/10.1182/blood.V106.11.705.705
Published: 2005
Journal Articles

Lessened severe graft-versus-host after “minitransplantations”

Mohamed Sorror, Michael Maris, Razvan Diaconescu, Rainer Storb
Journal: Blood
Blood (2005) 105 (6): 2614.
https://doi.org/10.1182/blood-2004-10-4039
Published: 2005